The neurosurgical robotics market in North America is expected to grow from US$ 797.59 million in 2022 to US$ 1,962.60 million by 2028. It is estimated to grow at a CAGR of 16.2% from 2022 to 2028.
The growing prevalence of neurological disorders, including epilepsy, Parkinson’s disease, head injury, brain tumors, brain stroke, and hydrocephalus, raises the need for neurosurgeries. Also, several subspecialties of neurosurgery such as pediatric neurosurgery, functional neurosurgery, neurovascular surgery, traumatology, skull-base surgery, and spinal surgery are among the most technical and skilled areas of surgery.
As per the data published by Centers for Disease Control and Prevention (CDC), the US recorded ~223,135 traumatic brain injury (TBI)-related hospitalizations in 2019 and 64,362 TBI-related deaths in 2020. Also, as per an article published in 2022 in The Lancet entitled, every year a million new cases of TBI are reported in the region. TBI can be treated by neurosurgical procedures. Therefore, the rising cases of TBI due to several factors, including falls, sports injuries, road accidents, domestic violence, and military incidents, propel the demand for neurosurgical procedures.
According to World Health Organization (WHO) data published in June 2022, millions of people suffer from epilepsy, and it is one of the most common neurological diseases. Among all, nearly 80% of epilepsy patients are in low- and middle-income countries. The patients who poorly respond to drug treatment undergo surgery. Therefore, the growing incidence of epilepsy propels the need for neurosurgical procedures. Thus, increase in the number of neurosurgeries drives the growth of the North America neurosurgical robotics market.
The US is home to key market leaders in the medical device industry. Also, various international players have their manufacturing facilities across the country. These players are constantly involved in new product development, and thus, enabling the launch of various innovative products.
The growing prevalence of neurological disorders, including epilepsy, Parkinson’s disease, head injury, brain tumors, brain stroke, and hydrocephalus, raises the need for neurosurgeries. Also, several subspecialties of neurosurgery such as pediatric neurosurgery, functional neurosurgery, neurovascular surgery, traumatology, skull-base surgery, and spinal surgery are among the most technical and skilled areas of surgery.
As per the data published by Centers for Disease Control and Prevention (CDC), the US recorded ~223,135 traumatic brain injury (TBI)-related hospitalizations in 2019 and 64,362 TBI-related deaths in 2020. Also, as per an article published in 2022 in The Lancet entitled, every year a million new cases of TBI are reported in the region. TBI can be treated by neurosurgical procedures. Therefore, the rising cases of TBI due to several factors, including falls, sports injuries, road accidents, domestic violence, and military incidents, propel the demand for neurosurgical procedures.
According to World Health Organization (WHO) data published in June 2022, millions of people suffer from epilepsy, and it is one of the most common neurological diseases. Among all, nearly 80% of epilepsy patients are in low- and middle-income countries. The patients who poorly respond to drug treatment undergo surgery. Therefore, the growing incidence of epilepsy propels the need for neurosurgical procedures. Thus, increase in the number of neurosurgeries drives the growth of the North America neurosurgical robotics market.
Market Overview
The North America neurosurgical robotics market is segmented into the US, Canada, and Mexico. The US holds the largest share of the North American neurosurgical robotics market. The market in North America is expected to grow owing to the factors such as the wide availability of competitors, rising product approvals, rising prevalence of neurological disorders, coupled with an increasing number of neurosurgical procedures, and well-established healthcare infrastructure. The neurosurgical robotics market is further driven due to the surge in the adoption of neurosurgical robotics and increasing number of MIS procedures compared to conventional approaches, and players launching technologically advanced products in neurosurgery space.The US is home to key market leaders in the medical device industry. Also, various international players have their manufacturing facilities across the country. These players are constantly involved in new product development, and thus, enabling the launch of various innovative products.
North America Neurosurgical Robotics Market Segmentation
The North America neurosurgical robotics market is segmented into component, application, surgery type, end user, and country.- Based on component, the North America neurosurgical robotics market is segmented into equipment/system, accessories, and services. The equipment/system segment is further segmented into robot machines, navigation system, planner & simulators, and others. The accessories segment is anticipated to hold the largest share of the market in 2022. The North America neurosurgical robotics market, based on application, is segmented into spinal and cranial. Spinal application is further segmented into spinal fusion, laminectomy, disc replacement, discectomy, foraminotomy, and others. The cranial segment is also subsegmented into brain biopsy, thermal ablation of seizure, surgical treatment of movement disorders, and others. In 2022, the spinal segment is anticipated to hold the largest share of the market, by application.
- Based on end user, the North America neurosurgical robotics market is segmented into hospitals, specialty centers, and others. In 2022, the hospitals segment is anticipated to hold the largest share of the market.
- Based on country, the market is segmented into the US, Canada, and Mexico. The US is anticipated to dominate the market in 2022. Accuray Incorporated; B. Braun Melsungen AG; Brainlab AG; Globus Medical, Inc.; Medtronic; NuVasive, Inc.; NuVasive, Inc; Renishaw plc; Synaptive Medical, Inc.; and Zimmer Biomet are among the leading companies operating in the neurosurgical robotics market in the region.
Table of Contents
1. Introduction
3. Research Methodology
4. Neurosurgical Robotics Market - Market Landscape
5. North America Neurosurgical Robotics Market- Key Market Dynamics
6. Neurosurgical Robotics Market- North America Analysis
7. North America Neurosurgical Robotics Market Analysis - By Component Type
8. North America Neurosurgical Robotics Market Analysis - By Application
9. North America Neurosurgical Robotics Market Analysis - By Surgery Type
10. North America Neurosurgical Robotics Market Analysis - By End-Users
11. North America Neurosurgical Robotics Market - Geographic Analysis
12. Neurosurgical Robotics Market-Industry Landscape
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Companies Mentioned
- Accuray Incorporated
- B. Braun Melsungen Ag
- Brainlab Ag
- Globus Medical, Inc.
- Medtronic; Nuvasive, Inc.
- Nuvasive, Inc
- Renishaw Plc
- Synaptive Medical, Inc.
- Zimmer Biomet
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 156 |
| Published | November 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( $ | $ 797.59 Million |
| Forecasted Market Value ( $ | $ 1962.6 Million |
| Compound Annual Growth Rate | 16.2% |
| Regions Covered | North America |
| No. of Companies Mentioned | 9 |
